iRhythm Holdings, Inc. (IRTC) Current Ratio
- Current ratio · latest quarter: Value 3.85×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 3.85× | Current assets / current liabilities. $755.95M ÷ $196.10M ≈ 3.85× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 755.95M USD | Assets, Current |
| Current obligations | 196.10M USD | Liabilities, Current |
| Cash and equivalents | 246.68M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | 344.60M USD | Marketable Securities, Current · Debt Securities, Available-for-sale, Current · Available-for-sale Securities, Current |
| Customer receivables | 84.27M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory | 22.51M USD | Inventory, Net |
| Payables | 17.41M USD | Accounts Payable, Current |
| Borrowing debt due within one year | (m) | Long-term Debt, Current Maturities |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $755.95M | $196.10M | $246.68M | $344.60M | $84.27M | $22.51M | $17.41M | (m) | 3.85× |
| 2026-03-31 | $680.56M | $131.75M | $240.15M | $309.47M | $80.86M | $23.80M | $8.56M | (m) | 5.17× |
| 2025-12-31 | $702.76M | $151.89M | $236.01M | $347.75M | $75.71M | $21.63M | $2.26M | (m) | 4.63× |
| 2025-09-30 | $680.03M | $146.91M | $255.60M | $309.61M | $76.16M | $19.56M | $8.28M | (m) | 4.63× |
| 2025-06-30 | $663.92M | $132.21M | $309.11M | $236.44M | $82.15M | $18.40M | $12.78M | (m) | 5.02× |
| 2025-03-31 | $636.01M | $111.34M | $375.28M | $145.31M | $80.64M | $14.34M | $11.95M | (m) | 5.71× |
| 2024-12-31 | $645.82M | $110.92M | $419.60M | $115.96M | $79.94M | $14.04M | $7.22M | (m) | 5.82× |
| 2024-09-30 | $627.91M | $100.10M | $519.53M | $2.50M | $77.43M | $15.03M | $7.59M | (m) | 6.27× |
| 2024-06-30 | $677.51M | $97.89M | $550.55M | $10.90M | $85.51M | $15.43M | $13.43M | (m) | 6.92× |
| 2024-03-31 | $687.46M | $96.84M | $520.42M | $48.67M | $89.71M | $14.87M | $8.44M | (m) | 7.10× |
| 2023-12-31 | $230.81M | $107.37M | $36.17M | $97.59M | $61.48M | $13.97M | $5.54M | (m) | 2.15× |
| 2023-09-30 | $234.29M | $102.29M | $47.48M | $111.00M | $50.07M | $13.65M | $7.21M | (m) | 2.29× |
| 2023-06-30 | $242.14M | $89.41M | $61.58M | $103.16M | $51.11M | $14.48M | $7.15M | (m) | 2.71× |
| 2023-03-31 | $253.89M | $81.90M | $52.80M | $123.53M | $49.56M | $16.39M | $9.78M | (m) | 3.10× |
| 2022-12-31 | $288.77M | $89.10M | $78.83M | $134.31M | $49.92M | $15.15M | $7.52M | (m) | 3.24× |
| 2022-09-30 | $285.85M | $83.59M | $71.22M | $132.32M | $60.53M | $14.45M | $7.40M | (m) | 3.42× |
| 2022-06-30 | $284.82M | $70.42M | $101.25M | $103.24M | $57.38M | $14.42M | $5.99M | (m) | 4.04× |
| 2022-03-31 | $286.35M | $61.78M | $94.79M | $114.00M | $55.29M | $12.45M | $5.41M | (m) | 4.63× |
| 2021-12-31 | $305.52M | $87.85M | $127.56M | $111.57M | $46.43M | $10.27M | $10.51M | (m) | 3.48× |
| 2021-09-30 | $325.19M | $82.78M | $167.37M | $89.40M | $52.82M | $9.96M | $4.89M | (m) | 3.93× |
| 2021-06-30 | $335.57M | $73.02M | $138.87M | $116.79M | $63.42M | $9.26M | $8.95M | (m) | 4.60× |
| 2021-03-31 | $336.11M | $59.38M | $137.38M | $124.91M | $59.98M | $6.86M | $5.15M | (m) | 5.66× |
| 2020-12-31 | $377.82M | $65.67M | $88.63M | $246.59M | $29.93M | $5.31M | $4.37M | (m) | 5.75× |
| 2020-09-30 | $365.94M | $55.87M | $95.34M | $231.90M | $28.95M | $5.06M | $3.84M | (m) | 6.55× |
| 2020-06-30 | $146.53M | $47.31M | $81.73M | $33.20M | $22.88M | $4.99M | $5.01M | (m) | 3.10× |
| 2020-03-31 | $154.43M | $42.84M | $56.51M | $65.26M | $24.21M | $4.23M | $5.54M | (m) | 3.60× |
| 2019-12-31 | $172.79M | $52.07M | $20.46M | $120.09M | $23.87M | $4.04M | $8.24M | (m) | 3.32× |
| 2019-09-30 | $184.88M | $45.47M | $34.63M | $118.09M | $25.00M | $3.50M | $4.19M | (m) | 4.07× |
| 2019-06-30 | $92.22M | $35.37M | $15.98M | (m) | $26.69M | (m) | (m) | (m) | 2.61× |
| 2019-03-31 | $91.55M | $28.73M | $28.10M | (m) | $26.77M | (m) | (m) | (m) | 3.19× |
| 2018-12-31 | $104.30M | $30.33M | (m) | (m) | $19.79M | (m) | (m) | (m) | 3.44× |
| 2018-09-30 | $106.24M | $22.52M | (m) | (m) | $19.98M | (m) | (m) | (m) | 4.72× |
| 2018-06-30 | $108.59M | $19.89M | (m) | (m) | $18.00M | (m) | (m) | (m) | 5.46× |
| 2018-03-31 | $111.52M | $17.09M | (m) | (m) | $17.14M | (m) | (m) | (m) | 6.53× |
| 2017-12-31 | $119.76M | $21.39M | (m) | (m) | $13.13M | (m) | (m) | (m) | 5.60× |
| 2017-09-30 | $122.79M | $16.04M | $20.43M | $105.44M | $12.04M | $1.31M | $2.08M | $1.48M | 7.65× |
| 2017-06-30 | $123.82M | $15.20M | $16.25M | $106.64M | $10.85M | $1.23M | $2.66M | $1.47M | 8.15× |
| 2017-03-31 | $106.60M | $10.68M | $15.58M | $91.42M | $10.98M | $1.16M | $1.41M | (m) | 9.98× |
| 2016-12-31 | $118.61M | $13.21M | $51.64M | $100.34M | $9.41M | $1.39M | $2.10M | (m) | 8.98× |
| 2016-09-30 | $17.84M | $9.32M | $5.76M | (m) | $9.31M | $1.67M | $1.58M | (m) | 1.91× |
| 2015-12-31 | $32.83M | $8.78M | $25.21M | $1.25M | $5.58M | $1.15M | $1.46M | (m) | 3.74× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 |